Evaluation of the effectiveness of Nigel-7 capsule and black seed mixture on corona

ABSTRACT

ConditionCOVID-19.
U07.2 COVID-19, virus not identified, COVID-19;U07.2

InterventionIntervention 1 Intervention group Intervention groups will be two ones. Patients in the intervention group will receive the intervention drug (three capsules a day and ten grams of black seed mixture daily) that is made by Talaye sabze tooba company; in addition to the routine treatment (Azithromycin 250 mg daily for 10 days and Naproxen 250 mg twice a day for 10 days) . Intervention 2 Control group The control group will receive the routine treatment (Azithromycin 250 mg daily for 10 days and Naproxen 250 mg twice a day for 10 days) .

Primary outcome:Measurement of cough severity. Timepoint Day 1 before and at the end of treatment. Method of measurement Cough scoring form.;Severity of shortness of breath. Timepoint Day 1 before and at the end of treatment. Method of measurement Shortness Of Breath With Daily Activity (SOBDA) Questionnaire.;Lung radiologic changes. Timepoint At beginning and end of the study. Method of measurement Chest CT scan.

CriteriaInclusion criteria Male or female patients 18 years old and older with Coronavirus Disease 2019 (COVID-19)
Ground glass view at low-dose CT scan
Consciously completed consent form completed by the patient or the patient's supervisor

Exclusion criteria History of pulmonary malignancy
History of asthma or COPD
History of Disabling disease or malignancy
Liver or kidney disorders